Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin-Reference-Cited by-同舟云学术

Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin

Published:2013-09 Issue:5 Volume:6 Page:567-574
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ Cardiovasc Qual Outcomes

Author:

Zalesak Martin¹,Siu Kimberly¹,Francis Kevin¹,Yu Chen¹,Alvrtsyan Hasmik¹,Rao Yajing¹,Walker David¹,Sander Stephen¹,Miyasato Gavin¹,Matchar David¹,Sanchez Herman¹

Affiliation:

1. From Trinity Partners, Waltham, MA (M.Z., K.F., C.Y., H.A., Y.R., G.M., H.S.); Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT (K.S., D.W., S.S.); and Program in Health Services and Systems Research, Duke-NUS Graduate Medical School, Singapore, Republic of Singapore (D.M.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?

2. Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation.;Brown TM;J Manag Care Pharm,2012

3. Increasing Prevalence of Atrial Fibrillation and Flutter in the United States

4. Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.;Kneeland PP;Patient Prefer Adherence,2010

5. Prevalence of Diagnosed Atrial Fibrillation in Adults

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistence to rivaroxaban therapy for stroke prevention in clinical practice in Italy: Rationale and design of the RITMUS-AF prospective observational cohort study;IJC Heart & Vasculature;2023-08

2. Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry;American Journal of Therapeutics;2023-01-10

3. Comparative non-persistence in the first year of treatment with oral anticoagulants in patients with atrial fibrillation: A French comprehensive nationwide study;Archives of Cardiovascular Diseases;2022-11

4. Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study;Frontiers in Cardiovascular Medicine;2022-09-29

5. Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data;Turkish Journal of Medical Sciences;2022-01-01